Effect of RECIST revision on classification of target lesions and overall response in advanced gastric cancer patients

@article{Fuse2012EffectOR,
  title={Effect of RECIST revision on classification of target lesions and overall response in advanced gastric cancer patients},
  author={Nozomu Fuse and Emiko Nagahisa-Oku and Toshihiko Doi and Takahide Sasaki and Shogo Nomura and Takashi Kojima and Tomonori Yano and Makoto Tahara and Takayuki Yoshino and Atsushi Ohtsu},
  journal={Gastric Cancer},
  year={2012},
  volume={16},
  pages={324-328}
}
The Response Evaluation Criteria in Solid Tumors (RECIST) was revised in 2009, based on a large dataset of 6512 patients from 16 trials. However, no gastric cancer patients were included in those data. The purpose of this study was to clarify the difference between RECIST version 1.0 and version 1.1 in advanced gastric cancer. From 2004 to 2009, 129 consecutive patients with advanced gastric cancer received S-1 plus cisplatin as first-line treatment at the National Cancer Center Hospital East… CONTINUE READING

Citations

Publications citing this paper.

References

Publications referenced by this paper.
Showing 1-10 of 12 references

Similar Papers

Loading similar papers…